Numinus Wellness Inc., a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce Cedar Clinical Research is a top research site for MindMed’s Phase 2b study evaluating MM-120 for General Anxiety Disorder.
This is sponsored content issued on behalf of Numinus Wellness, please see full disclaimer here.